# Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment

> **NCT05042154** · NA · UNKNOWN · sponsor: **Atlantic Health System** · enrollment: 300 (estimated)

## Conditions studied

- Prevalence of OSA in Patients Hospitalized With COPD Exacerbation

## Interventions

- **DEVICE:** WatchPAT

## Key facts

- **NCT ID:** NCT05042154
- **Lead sponsor:** Atlantic Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-31
- **Primary completion:** 2022-10-31
- **Final completion:** 2023-01-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05042154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05042154, "Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05042154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*